Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar

H Yazawa1, Z X Yu, Takeda

  • 1Laboratory of Molecular Immunoregulation, SAIC Frederick, Center for Cancer Research, National Cancer Institute at Frederick, Maryland 21702, USA.

Insights

The G-protein-coupled receptor FPRL1 facilitates the uptake of beta amyloid (Abeta42) into cells. Persistent Abeta42 exposure leads to fibril formation in macrophages via FPRL1.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Beta amyloid (Abeta42) is implicated in Alzheimer's disease (AD) neurotoxicity and mononuclear phagocyte activation.
  • FPRL1, a G-protein-coupled receptor, mediates Abeta42's effects on monocytes and microglia, suggesting its role in AD neuroinflammation.

Purpose of the Study:

  • To investigate the role of FPRL1 in the cellular uptake and fibril formation of Abeta42.
  • To elucidate the mechanism of Abeta42 internalization and subsequent aggregation in cells expressing FPRL1.

Main Methods:

  • Fluorescence confocal microscopy was employed to visualize Abeta42-FPRL1 interactions.
  • Macrophages and genetically engineered HEK293 cells expressing FPRL1 were used to study Abeta42 uptake and fibril formation.

Main Results:

  • Abeta42 rapidly associated with and was internalized into FPRL1-expressing cells (macrophages, HEK293) within 30 minutes.
  • FPRL1 recycled to the cell surface upon Abeta42 removal, while internalized Abeta42 was degraded.
  • Prolonged Abeta42 exposure (24h) led to Abeta42/FPRL1 complex retention and Congo red-positive fibril formation specifically in macrophages, not HEK293 cells.

Conclusions:

  • FPRL1 mediates Abeta42 internalization and contributes to fibril formation in macrophages.
  • The cellular context (macrophage vs. HEK293) influences Abeta42 fibril formation following FPRL1-mediated uptake.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...